Cardiovascular risk reclassification according to six cardiovascular risk algorithms and carotid ultrasound in

Dionicio A Galarza-Delgado1, Jose R Azpiri-Lopez2, Iris J Colunga-Pedraza1

  • 1Rheumatology Service, Internal Medicine Department, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico.

Clinical Rheumatology
|November 26, 2021
PubMed

Insights

Psoriatic arthritis patients have higher rates of subclinical atherosclerosis and cardiovascular risk. Carotid ultrasound can reclassify risk, indicating traditional algorithms underestimate actual cardiovascular risk in PsA.

Area of Science:

  • Rheumatology and Cardiology
  • Vascular Biology
  • Medical Imaging

Background:

  • Psoriatic arthritis (PsA) is associated with increased cardiovascular risk.
  • Subclinical atherosclerosis may be more prevalent in PsA patients.
  • Traditional cardiovascular risk (CVR) algorithms may underestimate CVR in PsA.

Purpose of the Study:

  • To compare subclinical atherosclerosis prevalence and CVR reclassification using six CVR algorithms and carotid ultrasound in PsA patients versus controls.
  • To evaluate the effectiveness of carotid ultrasound in identifying atherosclerosis not detected by standard CVR algorithms.

Main Methods:

  • Cross-sectional study involving 81 PsA patients and 81 matched controls (aged 40-75).
  • Evaluation of CVR using six algorithms: FRS-lipids, FRS-BMI, ASCVD, SCORE, QRISK3, and RRS.
  • Carotid ultrasound to detect carotid plaque (CP), defined by intima-media thickness or lumen narrowing.

Main Results:

  • CP and subclinical atherosclerosis were significantly more prevalent in PsA patients (44.4% vs 24.7% and 51.9% vs 33.3%, respectively).
  • Carotid ultrasound led to higher risk reclassification in PsA patients across all six CVR algorithms compared to controls.
  • Reclassification rates ranged from 28.4% (FRS-BMI) to 40.7% (SCORE) in PsA patients.

Conclusions:

  • PsA patients exhibit a higher burden of subclinical atherosclerosis.
  • Carotid ultrasound is valuable for reclassifying cardiovascular risk in PsA patients.
  • Current CVR algorithms underestimate the true cardiovascular risk in PsA, potentially delaying appropriate treatment.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
62
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
86
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
114
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
153
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
52